Lee Ainslie - Maverick Capital
Holding/activity history for Integra LifeSciences Holdings (IART)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q2 | 0 | 0 | Sell 100.00% | 0.01 | |
| 2024 Q1 | 9,419 | 0.01 | Add 8.87% | 0.00 | $35.46 |
| 2023 Q4 | 8,652 | 0.01 | Add 15.85% | 0.00 | $43.57 |
| 2023 Q3 | 7,468 | 0.01 | Reduce 26.02% | 0.00 | $38.16 |
| 2023 Q2 | 10,095 | 0.01 | Reduce 0.60% | 0.00 | $41.11 |
| 2023 Q1 | 10,156 | 0.01 | Add 65.76% | 0.00 | $57.40 |
| 2022 Q4 | 6,127 | 0.01 | Buy | 0.01 | $56.14 |
| 2021 Q4 | 0 | 0 | Sell 100.00% | 0.01 | |
| 2021 Q3 | 7,007 | 0.01 | Reduce 68.58% | 0.02 | $68.50 |
| 2021 Q2 | 22,299 | 0.01 | Add 126.34% | 0.01 | $68.25 |
| 2021 Q1 | 9,852 | 0.01 | Reduce 24.83% | 0.00 | $69.12 |
| 2020 Q4 | 13,106 | 0.01 | Reduce 37.27% | 0.01 | $64.93 |
| 2020 Q3 | 20,892 | 0.02 | Buy | 0.02 | $47.24 |